Established as an off-site public hospital compounding unit for the Auckland region
Manufacture freeze dried aseptic products, laboratory nutrient media, dialysis concentrates and all intravenous (IV) solutions for the three Auckland hospitals
Gained full manufacturing license from Medsafe. Traded in products that were previously supplied at no cost to pharmacies
Established a full management team and identified an overseas joint venture partner
Technology exchange between the Crown and an American multinational minority shareholder. Updated capability beyond glass IV packaging
Biomed fully and independently operated by B Braun USA and EBOS when Crown exited their shareholding
Management buyout of all shares. Fully New Zealand owned and operated from this date to present.